midazolam has been researched along with ridaforolimus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, N; Breidinger, S; Lush, R; McCrea, J; Narasimhan, N; Orford, K; Palcza, J; Panebianco, D; Papadopoulos, KP; Patnaik, A; Sandhu, P; Stroh, M; Talaty, J; Tolcher, A; Trucksis, M; Wagner, JA | 1 |
1 trial(s) available for midazolam and ridaforolimus
| Article | Year |
|---|---|
Lack of meaningful effect of ridaforolimus on the pharmacokinetics of midazolam in cancer patients: model prediction and clinical confirmation.
Topics: Aged; Anti-Anxiety Agents; Antineoplastic Agents; Area Under Curve; Drug Interactions; Female; Half-Life; Humans; Male; Midazolam; Middle Aged; Models, Biological; Sirolimus | 2014 |